SCHEMBL3343070

SCHEMBL3343070

Cc1ccc(-n2ccc(=O)n(C)c2=O)cc1C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
BRD4 O60885 2/20 0.38
KDM4E B2RXH2 1/20 0.38
BRPF1 P55201 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SIRT3 Q9NTG7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NNMT P40261 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
MAPK1 P28482 1/20 0.33
MAP2K2 P36507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6522040 0.82 F10 (0.43) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL3343075 0.79 ATAD2 (0.46) ALDH1A1SMN1; SMN2KDM4EBRPF1HSD17B10
SCHEMBL3340313 0.78 CRBN (0.46) ALDH1A1SMN1; SMN2BRD4MAPTGAA
SCHEMBL3342210 0.78 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL3342520 0.77 P2RX7 (0.47) ALDH1A1SMN1; SMN2KDM4EMAPTGAA
SCHEMBL6524527 0.75 CASP1 (0.40) ALDH1A1HSD17B10MAPTGAAMEN1
SCHEMBL3342474 0.72 POLB (0.47) ALDH1A1SMN1; SMN2KDM4EHSD17B10MAPT
SCHEMBL4591950 0.71 F10 (0.46) MAPK1
SCHEMBL3346082 0.70 KMT2A (0.44) ALDH1A1SMN1; SMN2MAPTGAAMEN1
SCHEMBL3224987 0.69 KMT2A (0.52) ALDH1A1SMN1; SMN2KDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 ALDH1A1 1506/4885SMN1; SMN2 2819/4885BRD4 1409/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 ALDH1A1 1357/4885SMN1; SMN2 3020/4885BRD4 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.